Concepedia

Brad Thompson

BT

Statistics

Publications

12

Citations

974

H-Index

11

Active since

2004

Affiliations

Oncolytics Biotech (Canada)(Current)

University of Guelph

Institute of Cancer Research

Public Health Agency of Canada

University of Calgary

Brad Thompson is an author at Oncolytics Biotech (Canada) specializing in medicine, oncology, and pharmacology.

Publications per year

2004–2022

12

Publications

12

A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed Recurrent Malignant Gliomas

Peter Forsyth, Glòria Roldán, David H. George et al. · Molecular Therapy · 2008 · 280 citations · Full text

Medicine, Oncology, Chemotherapy +12

Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies

Eleni Karapanagiotou, Victoria Roulstone, Katie Twigger et al. · Clinical Cancer Research · 2012 · 187 citations · Full text

Medicine, Oncology, Pharmacology +15

REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors

Don Morris, Xiaolan Feng, Lisa Difrancesco et al. · Investigational New Drugs · 2012 · 108 citations

Medicine, Oncology, Surgery +6

Enhanced <i>In vitro</i> and <i>In vivo</i> Cytotoxicity of Combined Reovirus and Radiotherapy

Katie Twigger, Laura Vidal, Christine L. White et al. · Clinical Cancer Research · 2008 · 104 citations

Medicine, Oncology, Radiation Oncology +17

A phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma

Devalingam Mahalingam, Christos Fountzilas, Jennifer L. Moseley et al. · Cancer Chemotherapy and Pharmacology · 2017 · 94 citations

Medicine, Oncology, Pharmacology +14

1–5 of 12